BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15518048)

  • 41. [Antiphospholipid syndrome diagnosis: an update].
    Visseaux B; Masliah-Planchon J; Fischer AM; Darnige L
    Ann Biol Clin (Paris); 2011; 69(4):411-8. PubMed ID: 21896405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin.
    Sheng Y; Hanly JG; Reddel SW; Kouts S; Guerin J; Koike T; Ichikawa K; Sturgess A; Krilis SA
    Clin Exp Immunol; 2001 Jun; 124(3):502-8. PubMed ID: 11472415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D; Boutière B; Sanmarco M
    Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
    Asherson RA; Cervera R; Merrill JT; Erkan D
    Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies.
    Roubey RA
    Blood; 1994 Nov; 84(9):2854-67. PubMed ID: 7949161
    [No Abstract]   [Full Text] [Related]  

  • 46. [Laboratory diagnosis of antiphospholipid syndrome].
    Darnige L
    Rev Med Interne; 2006 Apr; 27(4):296-301. PubMed ID: 16236386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome.
    Bećarević M; Sarić M; Stojanovich L; Mirković D; Dopsaj V; Ignjatović S
    Clin Rheumatol; 2018 Dec; 37(12):3359-3364. PubMed ID: 29948348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IgA anticardiolipin antibodies--relation with other antiphospholipid antibodies and clinical significance.
    Selva-O'Callaghan A; Ordi-Ros J; Monegal-Ferran F; Martinez N; Cortes-Hernandez F; Vilardell-Tarres M
    Thromb Haemost; 1998 Feb; 79(2):282-5. PubMed ID: 9493576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical approach to antiphospholipid syndrome: from facts to questions].
    Piette JC; Wechsler B; Blétry O; Frances C
    Presse Med; 1992 Dec; 21(43):2081-4. PubMed ID: 1297117
    [No Abstract]   [Full Text] [Related]  

  • 50. [Renal artery thrombosis revealing antiphospholipid antibody syndrome].
    Arache W; Bahadi A; Kabbaj DE
    Pan Afr Med J; 2018; 31():150. PubMed ID: 31037210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of extractable nuclear antigen, anti-double stranded DNA, antiphospholipid antibody, and anticardiolipin antibody positivity on obstetrical complications and pregnancy outcomes.
    Tanacan A; Beksac MS; Orgul G; Duru S; Sener B; Karaagaoglu E
    Hum Antibodies; 2019; 27(2):135-141. PubMed ID: 30856108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH.
    Devreese KM; Pierangeli SS; de Laat B; Tripodi A; Atsumi T; Ortel TL;
    J Thromb Haemost; 2014 May; 12(5):792-5. PubMed ID: 24589091
    [No Abstract]   [Full Text] [Related]  

  • 53. Women's Issues in Antiphospholipid Syndrome.
    Papadakis E; Banti A; Kioumi A
    Isr Med Assoc J; 2016 Sep; 18(9):524-529. PubMed ID: 28471597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antigenic specificities of antiphospholipid autoantibodies: implications for clinical laboratory testing and diagnosis of the antiphospholipid syndrome.
    Roubey RA
    Lupus; 1996 Oct; 5(5):425-30. PubMed ID: 8902774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticardiolipin test and the antiphospholipid (Hughes) syndrome: 20 years and counting!
    Harris EN; Khamashta M
    J Rheumatol; 2004 Nov; 31(11):2099-101. PubMed ID: 15517617
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
    Galli M
    Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Antiphospholipid antibodies (aPL): detection and clinical significance].
    Grunebaum L; Kheiralla JC; Wiesel ML; Freyssinet JM; Goetz J; Imler M; Cazenave JP
    Rev Med Interne; 1992; 13(4):307-14. PubMed ID: 1287776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies.
    Cervera R; Espinosa G
    Expert Opin Ther Targets; 2010 Dec; 14(12):1279-82. PubMed ID: 21058919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis of antiphospholipid antibodies.
    Petri M
    Rheum Dis Clin North Am; 1994 May; 20(2):443-69. PubMed ID: 8016420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A possible solution to the paradox of the "lupus anticoagulant": antiphospholipid antibodies accelerate thrombin generation by inhibiting annexin-V.
    Rand JH; Wu XX; Giesen P
    Thromb Haemost; 1999 Oct; 82(4):1376-7. PubMed ID: 10544942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.